Supplier Qualification and Material Selection – A Case Study of Biopharmaceutical Resin Manufacture
A one-time evaluation is not sufficient in that any changes that a supplier might make in their source, their production process, or a myriad of other items could impact the raw material quality and thus would impact drug manufacturing and ultimately could impact drug availability to patients. Thus, raw materials require continuous monitoring using a drug life cycle approach.